| scholarly article | Q13442814 |
| P356 | DOI | 10.1177/193229680900300504 |
| P8608 | Fatcat ID | release_eosdhlt62jcwjl7xlj4akywmee |
| P932 | PMC publication ID | 2769890 |
| P698 | PubMed publication ID | 20144414 |
| P5875 | ResearchGate publication ID | 41418826 |
| P50 | author | Claudio Cobelli | Q49943995 |
| Chiara Dalla Man | Q53534777 | ||
| Lalo Magni | Q53537152 | ||
| Eric Renard | Q61162479 | ||
| Daniela Bruttomesso | Q65013042 | ||
| Andrea Facchinetti | Q65013130 | ||
| Angelo Avogaro | Q87998934 | ||
| Alberto Maran | Q88253997 | ||
| Anne Farret | Q88413158 | ||
| Giuseppe De Nicolao | Q107417258 | ||
| P2093 | author name string | Jerome Place | |
| Maria Cristina Marescotti | |||
| Antonio Tiengo | |||
| Monica Vettore | |||
| Silvana Costa | |||
| Stefania Guerra | |||
| P2860 | cites work | Model predictive control of type 1 diabetes: an in silico trial | Q30437991 |
| In silico preclinical trials: a proof of concept in closed-loop control of type 1 diabetes | Q30439654 | ||
| Prandial insulin dosing using run-to-run control: application of clinical data and medical expertise to define a suitable performance metric | Q31101170 | ||
| The subcutaneous route to insulin-dependent diabetes therapy | Q32042368 | ||
| Implantable closed-loop glucose-sensing and insulin delivery: the future for insulin pump therapy | Q35026130 | ||
| Continuous glucose monitoring and closed-loop systems | Q36367034 | ||
| Closed-loop control and advisory mode evaluation of an artificial pancreatic Beta cell: use of proportional-integral-derivative equivalent model-based controllers | Q37404228 | ||
| An Artificial Endocrine Pancreas | Q39323639 | ||
| Closed-loop and Open-loop Devices for Blood Glucose Control in Normal and Diabetic Subjects | Q39782688 | ||
| Nonlinear model predictive control of glucose concentration in subjects with type 1 diabetes. | Q40480952 | ||
| Interstitial fluid glucose dynamics during insulin-induced hypoglycaemia | Q42480892 | ||
| Feasibility of automating insulin delivery for the treatment of type 1 diabetes | Q42604696 | ||
| Physiological differences between interstitial glucose and blood glucose measured in human subjects | Q44526994 | ||
| Timing of changes in interstitial and venous blood glucose measured with a continuous subcutaneous glucose sensor | Q44631829 | ||
| Run-to-run control of meal-related insulin dosing | Q45288053 | ||
| Detection of a meal using continuous glucose monitoring: implications for an artificial beta-cell | Q46047598 | ||
| Fully automated closed-loop insulin delivery versus semiautomated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas | Q46770123 | ||
| Meal simulation model of the glucose-insulin system | Q46958119 | ||
| A model-based algorithm for blood glucose control in type I diabetic patients | Q49087508 | ||
| Model-based blood glucose control for Type 1 diabetes via parametric programming. | Q51144135 | ||
| Run-to-run control of blood glucose concentrations for people with Type 1 diabetes mellitus. | Q51184704 | ||
| Does physiological blood glucose control require an adaptive control strategy? | Q69217970 | ||
| P433 | issue | 5 | |
| P921 | main subject | pancreas | Q9618 |
| glucose | Q37525 | ||
| glycobiology | Q899224 | ||
| preproinsulin | Q7240673 | ||
| P304 | page(s) | 1014-1021 | |
| P577 | publication date | 2009-09-01 | |
| P1433 | published in | Journal of Diabetes Science and Technology | Q15755249 |
| P1476 | title | Closed-loop artificial pancreas using subcutaneous glucose sensing and insulin delivery and a model predictive control algorithm: preliminary studies in Padova and Montpellier | |
| P478 | volume | 3 |
| Q34564238 | A bihormonal closed-loop artificial pancreas for type 1 diabetes |
| Q37154369 | A review of artificial pancreas technologies with an emphasis on bi-hormonal therapy |
| Q38201266 | Adaptive control of artificial pancreas systems - a review. |
| Q38260399 | Advances in management of type 1 diabetes mellitus |
| Q30409797 | Algorithms for a closed-loop artificial pancreas: the case for model predictive control |
| Q30409801 | Algorithms for a closed-loop artificial pancreas: the case for proportional-integral-derivative control |
| Q35682836 | An integrated multivariable artificial pancreas control system |
| Q37406020 | Applicability results of a nonlinear model-based robust blood glucose control algorithm |
| Q34055294 | Artificial pancreas (AP) clinical trial participants' acceptance of future AP technology |
| Q34243374 | Automated control of an adaptive bihormonal, dual-sensor artificial pancreas and evaluation during inpatient studies |
| Q33569031 | Autonomous and continuous adaptation of a bihormonal bionic pancreas in adults and adolescents with type 1 diabetes |
| Q41458753 | Challenges and Recent Progress in the Development of a Closed-loop Artificial Pancreas |
| Q36720439 | Clinical evaluation of a personalized artificial pancreas |
| Q33642470 | Clinical evaluation of an automated artificial pancreas using zone-model predictive control and health monitoring system |
| Q30424297 | Closed-loop insulin delivery utilizing pole placement to compensate for delays in subcutaneous insulin delivery |
| Q43170486 | Closed-loop insulin delivery: is the Holy Grail near? |
| Q42874742 | Closing the loop: another step forward |
| Q30429984 | Combining basal-bolus insulin infusion for tight postprandial glucose control: an in silico evaluation in adults, children, and adolescents |
| Q30434937 | Control to range for diabetes: functionality and modular architecture |
| Q35682750 | Design of the Glucose Rate Increase Detector: A Meal Detection Module for the Health Monitoring System |
| Q30409823 | DiAs user interface: a patient-centric interface for mobile artificial pancreas systems |
| Q30409819 | DiAs web monitoring: a real-time remote monitoring system designed for artificial pancreas outpatient trials |
| Q30416241 | Diabetes technology: markers, monitoring, assessment, and control of blood glucose fluctuations in diabetes |
| Q30434551 | Diabetes: Models, Signals, and Control |
| Q41261537 | Efficacy determinants of subcutaneous microdose glucagon during closed-loop control |
| Q36332293 | Fabrication of a Flexible Amperometric Glucose Sensor Using Additive Processes |
| Q56334391 | Identifiability Analysis of Three Control-Oriented Models for Use in Artificial Pancreas Systems |
| Q34076632 | Insulin patch pumps: their development and future in closed-loop systems |
| Q47778034 | Manual Closed-Loop Insulin Delivery Using a Saddle Point Model Predictive Control Algorithm: Results of a Crossover Randomized Overnight Study |
| Q37421657 | Model-based closed-loop glucose control in type 1 diabetes: the DiaCon experience |
| Q30370427 | Modular closed-loop control of diabetes |
| Q30415524 | Multilevel model of type 1 diabetes mellitus patients for model-based glucose controllers |
| Q30429989 | Multinational study of subcutaneous model-predictive closed-loop control in type 1 diabetes mellitus: summary of the results |
| Q33444545 | Multisite Study of an Implanted Continuous Glucose Sensor Over 90 Days in Patients With Diabetes Mellitus |
| Q36813568 | Multivariable adaptive closed-loop control of an artificial pancreas without meal and activity announcement. |
| Q64072341 | Optimal regulation of blood glucose level in Type I diabetes using insulin and glucagon |
| Q39321507 | Physiology-Invariant Meal Detection for Type 1 Diabetes |
| Q36605837 | Pilot study of a prototype minimally invasive intradermal continuous glucose monitor |
| Q34018134 | Postprandial glycemic excursions with the use of a closed-loop platform in subjects with type 1 diabetes: a pilot study |
| Q42599316 | Progress in development of an artificial pancreas |
| Q30370086 | Quantification of the glycemic response to microdoses of subcutaneous glucagon at varying insulin levels. |
| Q35682682 | Role of glucagon-like peptide-1 analogue versus amylin as an adjuvant therapy in type 1 diabetes in a closed loop setting with ePID algorithm |
| Q30434940 | Run-to-run tuning of model predictive control for type 1 diabetes subjects: in silico trial |
| Q34315968 | Safety of closed-loop therapy during reduction or omission of meal boluses in adolescents with type 1 diabetes: a randomized clinical trial |
| Q30384396 | Safety of outpatient closed-loop control: first randomized crossover trials of a wearable artificial pancreas |
| Q46487438 | The "Glucositter" overnight automated closed loop system for type 1 diabetes: a randomized crossover trial |
| Q37962829 | The OmniPod Insulin Management System: the latest innovation in insulin pump therapy |
| Q34894471 | The effect of insulin feedback on closed loop glucose control |
| Q33439009 | The use of an automated, portable glucose control system for overnight glucose control in adolescents and young adults with type 1 diabetes |
| Q38131064 | The use of reinforcement learning algorithms to meet the challenges of an artificial pancreas |
| Q37972360 | Towards an artificial pancreas at home |
| Q30416614 | Use of a food and drug administration-approved type 1 diabetes mellitus simulator to evaluate and optimize a proportional-integral-derivative controller |
| Q38044675 | Wearable and implantable pancreas substitutes |
Search more.